Transcription of 2. QUALITATIVE AND QUANTITATIVE …
{{id}} {{{paragraph}}}
180220 Ciproxin DS Page 1 of 28 NEW ZEALAND DATA SHEET 1. CIPROXIN Ciproxin 250 mg, film-coated tablets Ciproxin 500 mg, film-coated tablets Ciproxin 750 mg, film-coated tablets Ciproxin 50 mg/mL, oral suspension Ciproxin 100 mg/mL, oral suspension* Ciproxin 2 mg/mL, solution for infusion * currently available 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Film-coated tablets Ciproxin 250 mg: 1 tablet contains 291 mg ciprofloxacin hydrochloride monohydrate, corresp. to 250 mg ciprofloxacin Ciproxin 500 mg: 1 tablet contains 582 mg ciprofloxacin hydrochloride monohydrate, corresp. to 500 mg ciprofloxacin Ciproxin 750 mg: 1 tablet contains 873 mg ciprofloxacin hydrochloride monohydrate, corresp. to 750 mg ciprofloxacin Oral suspension Ciproxin 50 mg/mL: 1 bottle consists of g of microcapsules which contain g ciprofloxacin 1 bottle with g suspension diluent to prepare 100 mL of Ciproxin Suspension 5 % 1 measuring spoonful (approx.)
For the indication of inhalational anthrax (post-exposure), the risk-benefit assessment indicates that treatment of paediatric patients with ciprofloxacin is appropriate.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
CEFDINIR FOR ORAL SUSPENSION USP, Fluconazole 50mg 5ml Powder for Oral, Fluconazole 50mg/5ml Powder for Oral Suspension, Colestipol hydrochloride 5 g granules for oral, Colestipol hydrochloride 5 g granules for oral suspension . PRESENTATION, Aprepitant, For oral suspension, Nurofen, Oral Suspension, Package leaflet: Information for the user, SUSPENSION, FORMULA SHEET – NON-STERILE MANUFACTURING, SCHOOL SUSPENSION COORDINATOR, SCHOOL SUSPENSION COORDINATOR GENERAL RESPONSIBILITIES, Prescribing information